+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Recombinant Collagen Sterile Dressing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120666
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical recombinant collagen sterile dressings are redefining advanced wound care by combining high-performance biocompatibility with stringent safety standards and innovative therapeutic design. The global market is evolving rapidly as healthcare providers and manufacturers adapt to new regulatory frameworks, emerging technologies, and shifting demographic pressures, pushing the sector towards more sustainable and effective patient care solutions.

Market Snapshot: Medical Recombinant Collagen Sterile Dressing Market

The medical recombinant collagen sterile dressing market is experiencing robust adoption driven by the need for precise, reliable wound management solutions. Advanced recombinant technology delivers consistent structural properties and minimizes risks traditionally associated with animal-derived collagens. Growth is sustained by rising incidences of chronic conditions and increased focus on post-surgical wound care, with investment concentrated in markets with mature healthcare reimbursement policies and expanding R&D activities.

Scope & Segmentation of Medical Recombinant Collagen Sterile Dressings

  • Application Areas: Burn care (first to third degree), chronic ulcers (including diabetic foot and venous leg ulcers), surgical dressings (external and internal), acute and chronic wound care
  • Type: Bovine collagen (bone, hide), fish collagen (cold, warm water), porcine skin-derived, synthetic peptides, recombinant proteins
  • Product Forms: Films (semi-permeable, transparent), hydrogels (pH or thermo-sensitive), powders (fine, granules), sponges (cross-linked, non-cross-linked)
  • End Users: Ambulatory surgery centers, general and specialty clinics, home care (assisted, self-care), private and public hospitals
  • Distribution Channels: Institutional and tender sales, hospital pharmacies, online pharmacies, chain and independent retail pharmacies
  • Regions: Americas (including the United States, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (UK, Germany, France, Saudi Arabia, South Africa, others), Asia-Pacific (China, India, Japan, Australia, Singapore and more)
  • Key Companies: 3M Company, Smith & Nephew plc, Johnson & Johnson, Coloplast A/S, Medtronic plc, Baxter International, Integra LifeSciences Holdings, Acelity L.P. Inc., B. Braun Melsungen, Mölnlycke Health Care AB
  • Technologies: Recombinant protein scaffolds with tunable porosity, integrated drug delivery, smart sensors, green manufacturing practices

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Innovation in recombinant protein engineering is elevating product performance, supporting accelerated healing in complex wound cases and delivering uniformity not possible in animal-sourced alternatives.
  • Greater regulatory scrutiny is influencing product development and supply chains, propelling investment in traceability, contamination control, and alignment with evolving sterility standards.
  • The market is segmented by nuanced clinical needs, requiring differentiation by wound etiology, user setting, and material provenance, which enables tailored product positioning and value-added service models.
  • Digital health integration and remote monitoring tools are being incorporated into dressing platforms, enabling real-time wound assessment and optimizing patient adherence across care pathways.
  • Leading competitors are leveraging R&D alliances and acquisitions to extend technology portfolios, while actively strengthening manufacturing resilience and expanding into new geographic markets.
  • Emerging sustainability imperatives are causing manufacturers to invest in green production approaches without compromising clinical outcomes or regulatory compliance.

Tariff Impact: Navigating US 2025 Policy Changes

Forthcoming United States tariff adjustments for 2025 are expected to significantly alter the cost structure and sourcing approaches for medical recombinant collagen sterile dressings. Manufacturers are proactively reviewing production locations and supply chain resilience to limit exposure to trade disruptions. Providers and distributors are adapting inventory and procurement strategies to ensure consistent product access as regulatory and pricing pressures intensify. Scenario planning and harmonization of quality standards will be vital for maintaining competitiveness.

Methodology & Data Sources

This analysis is underpinned by a multi-phase research approach, combining systematic reviews of peer-reviewed journals, regulatory documents, and industry reports with structured interviews and surveys of clinicians, procurement managers, and market leaders. Triangulation techniques and peer review by subject matter experts ensure robust, actionable intelligence.

Why This Report Matters for Executive Stakeholders

  • Delivers targeted insights to inform strategic portfolio optimization and differentiate product offerings in a competitive market landscape.
  • Empowers supply chain and procurement leaders with scenario-driven guidance on tariff impacts, regional risks, and regulatory trends.
  • Enables data-driven decision-making by mapping evolving technologies, emerging therapeutic areas, and shifting end-user requirements.

Conclusion

The medical recombinant collagen sterile dressing sector is transitioning towards more personalized, data-centric, and sustainable solutions. Decision-makers engaging with this report are equipped to drive competitive advantage and support superior patient outcomes as the industry evolves.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of recombinant collagen dressings integrated with controlled release growth factors for accelerated diabetic ulcer healing
5.2. Increasing use of lyophilized recombinant collagen matrices enabling extended shelf life and simplified supply chain logistics in wound care
5.3. Development of biosensor-enabled collagen dressings offering real-time monitoring of wound pH and infection biomarkers
5.4. Strategic alliances between biotech firms and medical device manufacturers driving innovation in recombinant collagen sterile dressing portfolios
5.5. Surge in regulatory approvals for recombinant human collagen wound dressings derived from yeast and plant-based expression systems
5.6. Integration of 3D bioprinting technologies to customize recombinant collagen scaffolds for complex wound geometries and tissue regeneration
5.7. Rising demand for ecofriendly recombinant collagen production methods reducing reliance on animal-derived raw materials in dressing manufacture
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Recombinant Collagen Sterile Dressing Market, by Application
8.1. Introduction
8.2. Burn Care
8.2.1. First Degree Burns
8.2.2. Second Degree Burns
8.2.3. Third Degree Burns
8.3. Chronic Ulcers
8.3.1. Diabetic Foot Ulcer
8.3.2. Venous Leg Ulcer
8.4. Surgical Dressings
8.4.1. External Dressings
8.4.2. Internal Dressings
8.5. Wound Care
8.5.1. Acute Wound
8.5.1.1. Surgical Wound
8.5.1.2. Trauma Wound
8.5.2. Chronic Wound
8.5.2.1. Diabetic Foot Ulcer
8.5.2.2. Pressure Ulcer
9. Medical Recombinant Collagen Sterile Dressing Market, by Type
9.1. Introduction
9.2. Bovine Collagen
9.2.1. Bone Derived
9.2.2. Hide Derived
9.3. Fish Collagen
9.3.1. Cold Water
9.3.2. Warm Water
9.4. Porcine Collagen
9.4.1. Skin Derived
9.5. Synthetic Collagen
9.5.1. Collagen Peptides
9.5.2. Recombinant Collagen
10. Medical Recombinant Collagen Sterile Dressing Market, by Product Form
10.1. Introduction
10.2. Films
10.2.1. Semi Permeable Films
10.2.2. Transparent Films
10.3. Hydrogels
10.3.1. PH Sensitive
10.3.2. Thermo Sensitive
10.4. Powders
10.4.1. Fine Powder
10.4.2. Granules
10.5. Sponges
10.5.1. Cross Linked
10.5.2. Non Cross Linked
11. Medical Recombinant Collagen Sterile Dressing Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.2.1. Multispecialty
11.2.2. Single Specialty
11.3. Clinics
11.3.1. General Clinics
11.3.2. Specialty Clinics
11.4. Home Care Settings
11.4.1. Assisted Care
11.4.2. Self Care
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
12. Medical Recombinant Collagen Sterile Dressing Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. Institutional Sales
12.2.2. Tender Sales
12.3. Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
12.5.1. Chain Pharmacies
12.5.2. Independent Pharmacies
13. Americas Medical Recombinant Collagen Sterile Dressing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Medical Recombinant Collagen Sterile Dressing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Medical Recombinant Collagen Sterile Dressing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 3M Company
16.3.2. Smith & Nephew plc
16.3.3. Johnson & Johnson
16.3.4. Coloplast a/S
16.3.5. Medtronic plc
16.3.6. Baxter International Inc.
16.3.7. Integra LifeSciences Holdings Corporation
16.3.8. Acelity L.P. Inc.
16.3.9. B. Braun Melsungen AG
16.3.10. Mölnlycke Health Care AB
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET: RESEARCHAI
FIGURE 26. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET: RESEARCHSTATISTICS
FIGURE 27. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET: RESEARCHCONTACTS
FIGURE 28. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FIRST DEGREE BURNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FIRST DEGREE BURNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SECOND DEGREE BURNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SECOND DEGREE BURNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY THIRD DEGREE BURNS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY THIRD DEGREE BURNS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY EXTERNAL DRESSINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY EXTERNAL DRESSINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INTERNAL DRESSINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INTERNAL DRESSINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TRAUMA WOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TRAUMA WOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BONE DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BONE DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HIDE DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HIDE DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COLD WATER, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COLD WATER, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WARM WATER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WARM WATER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SKIN DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SKIN DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COLLAGEN PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COLLAGEN PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RECOMBINANT COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RECOMBINANT COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SEMI PERMEABLE FILMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SEMI PERMEABLE FILMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TRANSPARENT FILMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TRANSPARENT FILMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PH SENSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PH SENSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY THERMO SENSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY THERMO SENSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FINE POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FINE POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CROSS LINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CROSS LINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY NON CROSS LINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY NON CROSS LINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY MULTISPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY MULTISPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ASSISTED CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ASSISTED CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SELF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SELF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TENDER SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TENDER SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BURN CARE, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC ULCERS, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SURGICAL DRESSINGS, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY ACUTE WOUND, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY CHRONIC WOUND, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY BOVINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FISH COLLAGEN, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PORCINE COLLAGEN, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SYNTHETIC COLLAGEN, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY FILMS, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY HYDROGELS, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY POWDERS, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES MEDICAL RECOMBINANT COLLAGEN STERILE DRESSING MARKET SIZE, BY SPONGES, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES MEDICAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medical Recombinant Collagen Sterile Dressing market report include:
  • 3M Company
  • Smith & Nephew plc
  • Johnson & Johnson
  • Coloplast A/S
  • Medtronic plc
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Acelity L.P. Inc.
  • B. Braun Melsungen AG
  • Mölnlycke Health Care AB